20 articles
MIT's self-organizing laser creates ultra-sharp brain images 25x faster, enabling real-time tracking of drugs crossing the blood-brain barrier.
Reducing methionine and cysteine in diet activated calorie-burning beige fat as effectively as cold exposure, offering new weight loss insights.
Definium's single-dose LSD pill cut depression scores by 13 points vs 5 for placebo, with effects holding at 12 weeks.
Salk Institute researchers found methionine supplementation dramatically improved survival in infected mice by enhancing kidney filtration of inflammatory molecules.
Researchers created modified psilocin that maintains antidepressant effects while dramatically reducing psychedelic side effects in mice.
UC Davis scientists created novel brain-healing molecules that activate key serotonin receptors tied to neuroplasticity — without triggering hallucinations.
Scientists discover D-cysteine selectively targets cancer cells by disrupting their energy production without harming normal cells.
DiamiR and AlzLabs are combining protein biomarkers with microRNA signatures to match PET scan accuracy using a simple blood draw.
A Phase 1b trial shows a daily probiotic capsule may restore immunotherapy response in advanced melanoma patients who had stopped responding.
A class of modified amino acids found in dog blood may unlock new ways to measure and track biological aging across species.
A gut microbe converts a common pollutant into an inflammation trigger linked to depression, revealing a new molecular pathway.
New research finds every tested children's shirt from fast fashion retailers exceeded federal lead safety limits, posing brain development risks.
Scientists discover that subtle changes in blood protein structure can identify Alzheimer's earlier than current tests.
A modified B12 molecule delivers nitric oxide directly to glioblastoma tumors and boosts existing treatments in animal and lab studies.
An oral iron-targeting drug significantly slowed Multiple System Atrophy progression in a Phase 2 trial, with Phase 3 planning underway.
Researchers stabilized an impossible molecule in water, confirming how vitamin B1 drives essential biochemical reactions in our cells.
New research shows the tea you brew your kombucha with dramatically shapes its chemistry, antioxidant activity, and health potential.
Scientists used advanced brain imaging to reveal how ketamine reshapes key receptors in specific brain regions to quickly lift severe depression.
Adding an IL-6 blocker to standard anti-VEGF therapy improved visual acuity by 36% more than anti-VEGF alone in a randomized DME trial.
A molecule called OLE restores microglia's protective function, reducing amyloid plaques and improving memory in animal models.
